CJC-1295 without DAC occupies the sweet spot: longer-acting than sermorelin (which degrades too fast for reliable clinical effect), shorter-acting than DAC (which sacrifices pulsatility), and considerably cheaper than tesamorelin (the only FDA-approved option in this class)
Properties of quercetin conjugates: Modulation of LDL oxidation and binding to human serum albumin
Our findings were based on 113 RCTs, including 14 887 participants, and indicated that stimulants were the only intervention that was supported by evidence of efficacy in the short term (ie, at timepoints closest to 12 weeks) for core symptoms of ADHD in adults (both self-reported and clinician-reported) and was associated with good acceptability (all-cause discontinuation)
55 LynallM
Drug interactions have not been systematically evaluated
It is a reason to look at the full picture, weight, mood, hormones, sleep, and eating history, before beginning